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Background: Meningitis is an important cause of morbidity and mortality in low-resource settings. In sub-Saharan
Africa, the meningitis belt has been characterized by particularly high and seasonal incidences of bacterial
meningitis extending throughout life. Despite the progress being made in treating the condition, the mortality
rates continue to be high, ranging between 2% and 30% globally. In Ghana, the mortality rate of meningitis has
been estimated to range from 36% to 50%. However little information is available on the pathogens contributing to
meningitis and their antimicrobial susceptibilities. Updated information is essential to adjust the recommendations
for empirical treatment or prevention of meningitis which could have immense implications for local and
global health.
Methods: We retrospectively reviewed laboratory records of all patients suspected of bacterial meningitis who
underwent a lumbar puncture from January 1, 2008 to December 31, 2010. Data were retrieved from laboratory
record books and double entered into a MicrosoftW excel spreadsheet.
Results: Records of 4,955 cerebrospinal fluid samples were analysed. Of these, 163 (3.3%, 95%CI: 2.8% to 3.8%) were
confirmed meningitis and 106 (2.1%, 95%CI: 1.7% to 2.6%) were probable meningitis cases. Confirmed meningitis
cases were made up of 117 (71.8%) culture positive bacteria, 19 (11.7%) culture positive Cryptococcus neoformans
and 27(16.6%) Gram positive bacteria with negative culture. The most prevalent bacteria was Streptococcus
pneumoniae 91 (77.7%), followed by E.coli 4 (3.4%), Salmonella species 4 (3.4%), Neisseria meningitidis 3 (2.5%),
Pseudomonas species 3(2.5%) and others. Pneumococcal isolates susceptibility to penicillin, chloramphenicol and
ceftriaxone were 98.9% (95%CI: 94.0% to 100.0%), 83.0% (95%CI: 73.4% to 90.1%) and 100.0% (95%CI: 95.8% to
100.0%) respectively.
Conclusion: Streptococcus pneumoniae is an important cause of meningitis among all age groups and its
susceptibility to penicillin and ceftriaxone still remains very high. Ghanaians of all ages and possibly other
developing countries in the meningitis belt could benefit from the use of the pneumococcal vaccine. Other
bacterial and fungal pathogens should also be considered in the management of patients presenting
with meningitis.
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Cerebrospinal meningitis (CSM) is a major cause of
morbidity and mortality in many parts of the world [1-
3]. Despite the progress being made in treating the con-
dition, the mortality rates continue to be high, ranging
between 2% and 30% globally [4-6]. In Ghana, the mor-
tality rate of meningitis has been estimated to range
from 36% to 50% [7,8].
Apart from epidemics, at least 1.2 million cases of
meningitis are estimated to occur with estimated annual
deaths of 170,000 [9-11]. Complications such as epilepsy,
mental retardation, deafness and other related neuro-
logical defects are observed in 10% to 20% of those who
survive [12-14]. The estimated median risk of at least
one major or minor sequel from bacterial meningitis
after discharge from the hospital is 19.9% (range 12.3–
35.3%) [14]. In middle and low-income countries, acute
bacterial meningitis remains the fourth leading cause of
disability [14]. The prevalence of bacterial meningitis in
these countries is higher compared to developed
countries.
Bacterial meningitis is caused by a number of organ-
isms but beyond the neonatal period, over 90% of infec-
tions are caused by Streptococcus pneumoniae (S.
pneumoniae), Haemophilus influenza (H. influenza) and
Neisseria meningitidis (N. meningitidis) [14]. Over the
last two decades however, the causative agents of menin-
gitis has changed with the introduction of new highly ef-
fective vaccines [15]. Haemophilus influenzae type b
(Hib) used to be a common cause of bacterial meningitis
worldwide before the Hib vaccines [16]. However more
recently, S. pneumoniae and N. meningitidis have be-
come the major organisms causing meningitis. In coun-
tries with high HIV prevalence, Cryptococcus neoformans
may also be significant.
In many African countries including Ghana which lie
within the meningitis belt, epidemic cases of acute bac-
terial meningitis caused by different subtypes of N.
meningitidis and S. pneumoniae have been reported [17-
23]. However most of the data were collected during
outbreaks as such the pathogens detected were skewed
to S. pneumoniae and N. meningitidis. Information on
pathogens contributing to meningitis in hospital based
studies is limited. Two hospital based studies in Ghana
reported S. pneumoniae, N. meningitidis and H. influ-
enza as pathogens associated with meningitis [7,24].
However these studies were only conducted among few
populations of infants and children. Furthermore the
contributions of other bacterial and fungal agents were
not indicated.
Information from laboratory based surveillance is im-
portant in determining the most common aetiology of
meningitis pathogens. It is further necessary for improv-
ing the clinical management of cases, guiding therapeuticdecisions and for designing preventive strategies. In
Ghana for instance, the only vaccine given to protect
children at birth from meningitis is Haemophilus influ-
enza type b vaccine. Vaccines to protect individuals
against N. meningitidis are only given during outbreaks
and pneumococcal vaccines are yet to be introduced.
This study is therefore important as it provides infor-
mation on meningitis causing pathogens circulating
throughout the years and also justifies the importance of
vaccines or other control measures as a strategy for im-
proving population health. The aim of this study was
therefore to find out the different pathogens responsible
for meningitis and their antibiotic susceptibility patterns.
Methods
Study area
The study was carried out at the Komfo Anokye Teach-
ing Hospital (KATH), the second largest tertiary medical
facility in Ghana. KATH is approximately a one thou-
sand bed tertiary medical facility located in Kumasi, the
capital of Ashanti region with a total projected popula-
tion of 4,839,100. Kumasi lies in the central forest belt of
Ghana, situated at 6.720N 1.600W, approximately 290 m
above sea level and approximately 200km inland from
Atlantic coast. The teaching hospital apart from taking
care of patients located in the Ashanti region also
attends to referral cases from the northern, western and
eastern parts of Ghana. Its catchment population has
been estimated to be 10 million. The hospital attends to
an average of 400,000 out-patient cases and 41,000 in-
patients a year [25]. The mortality rate as estimated in
2009 was 8.66% with meningitis ranked as one of the
top ten causes of death [25].
The Ashanti region where the hospital is located has a
tropical climate with two rainy seasons, April—June and
September—November. During the period from Decem-
ber to March, the harmattan (a dry wind carrying dust
from the Sahara desert) blows across Ghana from the
northeast. Kumasi and the south of the country are most
affected by the harmattan in January and early February.
Study design and data collection
We retrospectively reviewed laboratory records of all
patients suspected of bacterial meningitis who under-
went lumbar puncture from January 1, 2008 to Decem-
ber 31, 2010. Data were retrieved from laboratory record
books and double entered unto MicrosoftW excel spread-
sheet. Demographic data, clinical diagnoses, isolated
organisms, cerebrospinal fluid (CSF) appearance and
antibiotic susceptibility profile of organisms were col-
lected. Six patients with bloody CSF appearance with no
organism isolated were excluded from the data. Similarly
any sample received from a patient who had a second
sample submitted within 3 weeks of the first sample was
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cocci with cell counts less than 10 cells/mm3 were
regarded as contaminants.
Case definitions
Cases collected from the laboratory records were classi-
fied into probable and confirmed meningitis. Probable
bacterial meningitis was defined as a case with no bac-
teria identified in the CSF but with leukocytosis of
greater than or equal to 100 white blood cell/mm3 with
greater than 60% being neutrophils [26-28]. A confirmed
case of meningitis was defined as one of the following:
Bacterial or cryptococcal isolation from CSF culture or a
positive Gram Stain with no bacterial growth [26,27].
CSF processing and bacterial or fungal culture
All CSF samples were processed at the bacteriology unit
of KATH using standard microbiology techniques. Stand-
ard CSF analysis includes physical evaluation (divided into
clear, hazy, cloudy, turbid, bloody and xanthochromic),
WBC count per ml (determined manually with a modified
Neubauer counting chamber) and differential white cell
count.
Microbiological analysis included direct wet mount,
Gram staining and India ink staining of the CSF deposits
and culturing on chocolate agar, blood agar and sabouraud
agar. All culture plates suspected of bacterial and fungal
organisms were incubated at 370C for 24–48 hours in 5%
carbon dioxide environment and room temperature re-
spectively. Any colonies observed were further processed
and pathogens identified by standard microbiological
techniques adapted from the WHO laboratory manual for
diagnosing bacterial meningitis [29]. N. meningitidis spe-
cies were identified by Gram stain, Oxidase test and col-
ony morphology while H. influenza identification was
based on X and V growth factors. Optochin sensitivity for
confirmation of S. pneumoniae was based on a zone size
of 14mm or more. Fungal growths on sabouraud agar
were confirmed using indian ink and analytical profile
index (bioMerieux, France).
All other bacteria isolates were identified using con-
ventional biochemical methods including urease and in-
dole production, citrate utilization, hydrogen sulphide
gas production and fermentation of sugars. The bio-
chemical media used included Simon’s Citrate medium,
Urea and Triple Sugar Iron agar (TSI).
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was done for all bac-
terial isolates using the Kirby-Bauer disk diffusion
method. The antibiotics used were ceftriaxone (30μg),
chloramphenicol (30μg), cefotaxime (30μg), oxacillin
(1μg), amikacin (30μg), gentamicin (10μg), and septrin
(23.75/1.25μg) (Oxoid, UK).Susceptibility testing was performed by inoculating
cultures directly in 0.85% saline and adjusted to a turbid-
ity of 0.5 McFarland using densitometer. Inocula were
poured on Nutrient Agar for non-fastidious organisms
and Chocolate agar for fastidious organisms. Plates were
read after overnight incubation and zone diameters were
interpreted according to zone recommendation from
CLSI. All isolates showing intermediate susceptibilities
were classified as sensitive. Penicillin resistance was
based on an oxacillin zone size of less than 19mm.
For all testing, control organisms received from the
world health organisation external quality control sup-
port were included.
Ethical approval
The study protocol was approved by the Committee for
Human Research, Publications and Ethics (CHRPE) of
KATH and School of Medical Sciences, KNUST,
Kumasi, Ashanti region, Ghana.
Statistical analysis
Data was exported to Stata SE version 11.2 for analysis. The
ages were stratified as follows: less than 1 month, 1 to < 5
years, 5 to < 18 years, 18 to < 50 years and greater than or
equal to 50 years. Proportions for the various organisms and
demographic features were expressed as percentages with or
without their binomial exact 95% confidence intervals.
Results
Over the three year period of 2008-2010, records of
4,955 CSF samples of suspected cases of meningitis were
analysed. Of these, 163 (3.3% 95%CI: 2.8% to 3.8%) were
confirmed meningitis and 106 (2.1%, 95%CI: 1.7% to
2.6%) were probable meningitis cases. The numbers of
confirmed meningitis cases were 64 in 2008, 41 in 2009
and 31 in 2010 whereas probable meningitis occurred in
75, 52 and 36 infected patients for the same periods re-
spectively (Table 1). Confirmed meningitis cases were
made up of 117 (71.8%) culture positive bacteria, 19
(11.7%) culture positive Cryptococcus neoformans and 27
(16.6%) Gram positive bacteria with negative culture.
There was a general reduction in the number of menin-
gitis cases over the three year period. The most preva-
lent bacteria was S. pneumoniae 91 (77.7%), followed by
E.coli 4 (3.4%) or Salmonella species 4 (3.4%), N. menin-
gitidis 3 (2.5%) or Pseudomonas species 3 (2.5%), Klebsi-
ella species 2 (1.7%) and Enterobacter species 1 (0.9%) or
H. influenza 1(0.9%). The majority of those infected with
S. pneumoniae 53 (58.2%) were below 18 years of age
and the highest cases of Cryptococcus neoformans 17
(89.4%) occurred among patients between 18 and 50
years. Other Gram negative rods such as Salmonella spe-
cies, Pseudomonas species, E.coli and H. influenza were
more common among children less than 5 years
Table 1 Yearly distribution of meningitis pathogens
Pathogens Year n (%)
2008 2009 2010 Total
N.meningitidis 0 2 (4.9) 1 (3.2) 3 (2.2)
S.pneumoniae 53 (82.8) 22 (53.7) 16 (51.6) 91 (66.9)
H.influenzae 0 0 1(3.2) 1 (0.7)
Cryptococcus neoformans 5 (7.8) 6 (14.6) 8 (25.8) 19 (14.0)
Pseudomonas species 0 0 1 (3.2) 1 (0.7)
Pseudomonas aeruginosa 0 0 2 (6.5) 2 (1.5)
E.coli 2 (3.1) 2 (4.9) 0 4 (2.9)
Klebsiella species 1 (1.6) 0 1 (3.2) 2 (1.5)
Staphylococcus aureus 0 3 (7.3) 0 3 (2.2)
Salmonella species 2 (3.1) 2 (4.9) 0 4 (2.9)
Enterobacter species 0 1 (2.4) 0 1 (0.7)
Coliforms 0 2 (4.9) 0 2 (1.5)
Coagulase negative
staphylococcus.
1 (1.6) 1 (2.4) 1 (3.2) 3 (2.2)
Total 64 (100.0) 41 (100.0) 31 (100.0) 136 (100.0)
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difference was however not significant.
The median cell count of patients infected with S. pneu-
moniae was 362.5 (55-1247) cells/mm3 and that of N.
meningitidis was 12700 (3,200-14000) cells/mm3. Results
of antimicrobial susceptibility testing of S. pneumoniae
and N. meningitidis isolates with penicillin, ceftriaxone
and cefotaxime shows almost all isolates were susceptible
(Table 3). Only twenty five percent of Salmonella spp iso-
lates were susceptible to chloramphenicol.
Seasonal variation of confirmed meningitis cases was
examined over the three year period (Figure 1). Con-
firmed meningitis cases were generally higher in the yearTable 2 Meningitis pathogens and age group distribution
Pathogens ≤ 1mth 1mth to <5y
N.meningitidis. 1(6.7) 0
S.pneumoniae 8(53.3) 21(70.0)
H.influenzae 0 1(3.3)
Salmonella species 1(6.7) 3(10.0)
Pseudomonas spp. 0 1(3.3)
Pseudomonas aeruginosa 2(13.3) 0
E.coli 1(6.7) 1(3.3)
Cryptococcus neoformans. 0 0
Staphylococcus aureus. 0 3(10.0)
Klebsiella species. 0 0
Enterobacter species 1(6.7) 0
Coliforms 1(6.8) 0
Coagulase negative staphylococcus 0 0
Total 15 (100.0) 30 (100.0)2008 compared to the other years. The highest peak oc-
curred in February 2008. Lower monthly prevalence was
however recorded in the year 2010 except for the month
of February.
Discussion
Cerebrospinal meningitis is a major cause of mortality
and morbidity in both children and adults. In Ghana,
cases of meningitis outbreaks are mostly reported in the
northern part of the country and has been attributed to
the low humidity in that area. In the years 1996-1997,
the three northern regions of Ghana for instance
recorded 18,703 cases of meningitis out of which 1,356
lost their lives during an outbreak. [30,31]. Similar cases
of meningitis have been reported in other parts of Ghana
[7,24,32] however hospital based information on the dif-
ferent aetiological agents, antimicrobial susceptibility
patterns and the seasonality is limited.
In our study the prevalence of confirmed and probable
meningitis were 3.3% and 2.1% respectively. Our result
is similar to other surveillance (based on cultures) of
meningitis in other parts of Africa [33,34]. The preva-
lence however appears low compared to some reports
from the northern part of Ghana. This is because our
reports were from all patients suspected of meningitis
while reports from northern Ghana were mostly
obtained during outbreaks. We however believe the
prevalence could have been higher if techniques using
polymerase chain reactions were applied in testing the
samples [35,36]. Another reason that could contribute to
the low meningitis prevalence is the possible use of anti-
biotics before hospital admission, a common practice in
many developing countries [35,37]. Even though we have
no records on the number of patients on antibioticsAge grouping (years) n(%)
rs 5yrs to <18yrs 18yrs to <50yrs >= 50yrs
1(3.4) 1(2.0) 0
24(82.8) 30(60.0) 8 (66.7)
0 0 0
0 0 0
0 0 0
0 0 0
0 1 (2.0) 1(8.3)
2(6.9) 15 (30.0) 2 (16.7)
0 0 0
0 1 (2.0) 1 (8.3)
0 0 0
0 1 (2.0) 0
2(6.9) 1 (2.0) 0
29 (100.0) 50 (100.0) 12 (100.0)
Table 3 Antimicrobial susceptibility patterns of meningitis pathogens
Percentage Sensitivity %(n/N)
Antibiotic Streptococcus
pneumoniae
Neisseria
meningitidis
Haemophilus
influenzae
Salmonella
species
Pseudomonas
species
E. coli Othersb
Penicillin 98.9 (89/90) 100.0 (3/3) 0(0/1) — – – 57.1 (4/7)
Chloramphenicol 83.0 (73/88) 100.0 (2/2) 100.0 (1/1) 25.0 (1/4) – 66.7 (2/3) 77.8 (7/9)
Ceftriaxone 100.0 (86/86) 100.0 (2/2) 100.0 (1/1) 100.0 (3/3) 100.0 (2/2) 100.0 (3/3) 83.3 (5/6)
Cefotaxime 100.0 (16/16) 100.0 (2/2) – 100.0 (3/3) – 66.7 (2/3) 50.0 (2/4)
Septrin – – – 0 (0/4) – 0 (0/3) 14.3 (1/7)
Ampicillin – – 0(0/1) 0 (0/3) – 0 (0/4) 14.3 (1/7)
Gentamycin – – – 100 (2/2) 50 (1/2) 50.0 (1/2) 60.0 (3/5)
Ceftazidime – – – 0 (0/1) 0 (0/2) – –
Amikacin – – – 100.0 (2/2) 50 (1/2) 100 (3/3) 100.0 (3/3)
Othersb: This represents the cumulative percentage of the following organisms: Klebsiella species, Enterobacter species, Staphylococcus aureus, Coagulase negative
staphylococcus and Coliforms. Pseudomonas species includes Pseudomonas aeruginosa organisms. Antibiotics were not tested against all organisms with dash (–).
Owusu et al. Annals of Clinical Microbiology and Antimicrobials 2012, 11:28 Page 5 of 8
http://www.ann-clinmicrob.com/content/11/1/28before admission, our observation show that most of the
admitted cases referred from other primary healthcare
facilities had been managed with antibiotics before refer-
ral. Future studies are however needed to confirm this.
The most prevalent bacteria was S. pneumoniae occur-
ring mostly among patients less than 18 years of age.
Neonates accounted for 8.7% and children from one
month to less than 5 years accounted for 23%. Our re-
sult is similar to previous studies done by Holliman
et al., [8] where they found majority of S. pneumoniae
infections occurred in children and young patients.
Adult pneumococcal meningitis which accounted for
41.8% of infections was equally significantly identified as
reported in other studies [38]. A possible reason for the
predominant prevalence of pneumococcal meningitis
could be as a result of auto-infection from colonizingFigure 1 Confirmed meningitis for all patients stratified by year. The
having confirmed meningitis.bacteria in the nasopharynx. Previous studies have
shown the prevalence of nasopharyngeal colonization
with streptococcal pneumoniae to be 51.4% [39] in
Ghana. The auto-transmission from the nasopharynx
into the meninges is therefore highly possible especially
during the dry season when cracks and injuries tend to
occur in the nasopharynx. Countries that introduced
pneumococcal conjugate vaccines have however
reported a reduction in the cases of pneumococcal men-
ingitis [40].
We found one case of H. influenzae over the three
year period. This low prevalence is quite remarkable and
could be explained by the introduction of Hib vaccines
in Ghana in 2002. The impact of Hib vaccine on the re-
duction of meningitis has been reported by Renner et al
[15]. Other developing countries such as Turkey havefigure describes the monthly distribution of all patients classified as
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however possible that the infected child may not have
been vaccinated against H. influenzae. Though the Hib
immunization status of the child with the Hib meningitis
could not be determined it is possible he might have
been born in a rural area where access to healthcare and
vaccination may be difficult. It is also possible that the
under reporting of meningitis cases might have contrib-
uted to the low numbers. This is because some devel-
oped countries like the USA which introduced vaccines
against Hib meningitis decades ago still reports preva-
lence of 6.7% [42].
The contribution of other bacteria pathogens to men-
ingitis apart from N. meningitidis, S. pneumoniae and
Haemophilus influenzae has not been widely reported in
many developing countries. The present study identified
E.coli, Salmonella species, Pseudomonas species, Klebsi-
ella species, Staphylococcus aureus and Enterobacter spe-
cies as contributing to 12% of all bacterial isolates
among children and infants. Some studies in developing
countries have similarly reported these observations [43-
45]. Contrary to these findings however, children and
neonates in developed countries have been reported to
have predominance of Group B streptococcus and Lys-
teria monocytogenes [46]. The reasons for the non-
identification of Lysteria monocytogenes in our laboratory
could be due to less attention given to the laboratory
diagnosis of this pathogen. This is because Lysteria
monocytogenes resembles diphtheroids and could easily
be regarded as contaminants. Furthermore reagents such
as esculin and hippurate hydrolysis or CAMP test
(Christie, Atkins and Munch-Peterson) used for con-
firming Lysteria monocytogenes are not readily available
in our laboratory.
Of interest in our study is the identification of Crypto-
coccus neoformans, occurring mostly in patients between
the ages of 18 and 50 years. Previous studies in Ghana
(Kumasi) did not identify Cryptococcus neoformans in
meningitis patients perhaps due to the small number of
study patients [32]. The identification of Cryptococcus
neoformans is however not surprising since the number
of people living with HIV/AIDS continue to increase
even though the national HIV prevalence had reduced
from 1.8% in 2008 to 1.5% in 2010. The contribution of
Cryptococcus neoformans to meningitis has similarly
been reported to mostly occur in HIV endemic African
countries [47-49].
All isolates tested with ceftriaxone were 100% suscep-
tible with the exception of Staphylococcus aureus. Eighty
three percent (83%) of S. pneumoniae isolates were sus-
ceptible to chloramphenicol whereas 98.9% were suscep-
tible to penicillin. Our study found no evidence of high
level resistance against chloramphenicol and penicillin.
Previous studies in Ghana have however documentedpneumococcal penicillin resistance rates varying from
8%-31% [7,8,50] and chloramphenicol resistance rates of
5-20.6% [50]. The difference in the resistance patterns
could be due to the methodology used. The sensitivity
patterns of our isolates were done using only the Kirby-
Bauer method which could underestimate the resistance
levels. On the other hand, the susceptibility of S. pneu-
moniae, N. meningitidis and H. influenzae to ceftriaxone
has been mostly reported to be 100% [24,39,50].
Appropriate treatment for meningitis depends on the
local antimicrobial susceptibility patterns. In Ghana, the
hospital antibiotic policy recommends penicillin and
chloramphenicol as the first choice of meningitis treat-
ment and ceftriaxone is considered as alternative [51].
This study therefore emphasizes the need for clinicians
to continuously rely on ceftriaxone as the best choice of
drug for the treatment of meningitis.
Seasonal distribution of confirmed meningitis cases
were noted to increase from December through January
and peaked in February of 2008 (figure 1). The next
highest peak of confirmed meningitis also occurred in
February of 2010. This trend is not surprising as the dry
season reaches its peak during these months and thus
provides the conditions for destruction of the mucosal
defences thus making individuals more susceptible to
meningitis [22,52]. These conditions may however not
entirely promote meningitis since the trend in 2009 was
quite different. More studies on seasonal variation is
therefore needed to understand the exact seasons that
significantly promote meningitis.
Conclusion
S. pneumoniae still remains a major cause of bacterial
meningitis among all age groups and its susceptibility to
penicillin, chloramphenicol and ceftriaxone still remains
high. Ghanaians of all ages and possibly other develop-
ing countries in the meningitis belt could benefit from
the use of the pneumococcal vaccine. The contribution
of other pathogens such as E.coli, Klebsiella species, Sal-
monella species and Cryptococcus neoformans in devel-
oping countries cannot be underestimated in the
treatment and management of meningitis. This study
emphasizes the need for extensive hospital based surveil-
lance of meningitis causing pathogens in developing
countries.
Abbreviations
CSM: Cerebrospinal Meningitis; HIV: Human immunodeficiency virus;
CSF: Cerebrospinal fluid; KATH: Komfo Anokye Teaching Hospital; WBC: White
blood cells; TSI: Triple Sugar Iron; CHRPE: Committee for Human Research,
Publication and Ethics; CLSI: Clinical and Laboratory Standards Institute; S.
pneumoniae: Streptococcus pneumoniae; H. influenzae: Haemophilus influenzae;
N. meningitidis: Neisseria meningitidis.
Competing interests
Authors have no competing interests.
Owusu et al. Annals of Clinical Microbiology and Antimicrobials 2012, 11:28 Page 7 of 8
http://www.ann-clinmicrob.com/content/11/1/28Authors' contributions
YAB, BBE, AAR and ALR co-worked on data collection and organisation. SBN
performed statistical analysis of the data and contributed to writing and
interpretation of the manuscript. O.M designed, initiated the study and
wrote the manuscript. YAS contributed to the design and writing of the
manuscript. All authors have read and approved the manuscript.Acknowledgement
We thank the department of clinical microbiology, KATH for supporting this
study.
Author details
1Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi,
Ghana. 2Department of Child Health, Komfo Anokye Teaching Hospital,
Kumasi, Ghana. 3Department of Microbiology, Komfo Anokye Teaching
Hospital, Kumasi, Ghana. 4Department of Clinical Microbiology, Kwame
Nkrumah University of Science and Technology, Kumasi, Ghana.
Received: 5 July 2012 Accepted: 29 September 2012
Published: 4 October 2012References
1. Peltola H: Meningococcal disease: still with us. Rev Infect Dis 1983,
5(1):71–91.
2. Theodoridou MN, et al: Meningitis registry of hospitalized cases in
children: epidemiological patterns of acute bacterial meningitis
throughout a 32-year period. BMC Infect Dis 2007, 7:101.
3. Dash N, et al: Acute bacterial meningitis among children < 5 years of age
in Oman: a retrospective study during 2000-2005. J Infect Dev Ctries 2008,
2(2):112–115.
4. Chavez-Bueno S, McCracken GH Jr: Bacterial meningitis in children. Pediatr
Clin North Am 2005, 52(3):795–810.
5. Perez AE, Dickinson FO, Rodriguez M: Community acquired bacterial
meningitis in Cuba: a follow up of a decade. BMC Infect Dis 2010, 10:130.
6. van de Beek D, et al: Clinical features and prognostic factors in adults
with bacterial meningitis. N Engl J Med 2004, 351(18):1849–1859.
7. Mackie EJ, et al: A study of bacterial meningitis in Kumasi, Ghana. Ann
Trop Paediatr 1992, 12(2):143–148.
8. Holliman RE, et al: Epidemiology of invasive pneumococcal disease in
Kumasi, Ghana. Trans R Soc Trop Med Hyg 2007, 101(4):405–413.
9. Tikhomirov E, Santamaria M, Esteves K: Meningococcal disease: public
health burden and control. World Health Stat Q 1997, 50(3–4):170–177.
10. World Health Organisation: New and under-utilized vaccines implementation
(NUVI): Bacterial Meningitis(online). 2011. cited 2011 13-04-2011];
Available from: http://www.who.int/nuvi/meningitis/en/index.html.
11. World Health Organization: Meningococcal meningitis [online]. 2011. cited
2011 18-02-2011]; Available from: http://www.who.int/mediacentre/
factsheets/fs141/en/index.html.
12. Grimwood K, et al: Twelve year outcomes following bacterial meningitis:
further evidence for persisting effects. Arch Dis Child 2000, 83(2):111–116.
13. Ramakrishnan M, et al: Sequelae due to bacterial meningitis among
African children: a systematic literature review. BMC Med 2009, 7:47.
14. Edmond K, et al: Global and regional risk of disabling sequelae from
bacterial meningitis: a systematic review and meta-analysis. Lancet Infect
Dis 2010, 10(5):317–328.
15. Renner LA, et al: Introduction of Haemophilus influenzae type B
conjugate vaccine into routine immunization in Ghana and its impact
on bacterial meningitis in children younger than five years. Pediatr Infect
Dis J 2007, 26(4):356–358.
16. Martin M, et al: Impact of haemophilus influenzae type b conjugate
vaccine in South Africa and Argentina. Pediatr Infect Dis J 2004,
23(9):842–847.
17. Weber MW, et al: Clinical predictors of bacterial meningitis in infants and
young children in The Gambia. Trop Med Int Health 2002, 7(9):722–731.
18. Besancenot JP, Boko M, Oke PC: Weather conditions and cerebrospinal
meningitis in Benin (Gulf of Guinea, West Africa). Eur J Epidemiol 1997,
13(7):807–815.
19. Greenwood B: Editorial: 100 years of epidemic meningitis in
West Africa - has anything changed? Trop Med Int Health 2006,
11(6):773–780.20. World Health Organisation: Meningitis in Burkina Faso, Chad, Niger,
Nigeria and Ghana: 2010 epidemic season. Wkly Epidemiol Rec 2011,
86(15):143–151.
21. Hodgson A, et al: Survival and sequelae of meningococcal meningitis in
Ghana. Int J Epidemiol 2001, 30(6):1440–1446.
22. Leimkugel J, et al: An outbreak of serotype 1 Streptococcus pneumoniae
meningitis in northern Ghana with features that are characteristic of
Neisseria meningitidis meningitis epidemics. J Infect Dis 2005,
192(2):192–199.
23. Yaro S, et al: Epidemiological and molecular characteristics of a highly
lethal pneumococcal meningitis epidemic in Burkina Faso. Clin Infect Dis
2006, 43(6):693–700.
24. Commey JO, et al: Bacterial meningitis in children in southern Ghana.
East Afr Med J 1994, 71(2):113–117.
25. Komfo Anokye Teaching Hospital: KATH annual report. Kumasi: Komfo
Anokye Teaching Hospital; 2009.
26. World Health Organization: Communicable disease case definitions toolkit.
Geneva: WHO/CDS; 2004:24.
27. World Health Organisation: Immunization surveillance, assessment and
monitoring. Bacterial meningitis (including Haemophilus influenzae type
b (Hib), Neisseria meningitidis, and Streptococcus pneumoniae). 2011,
[cited 2011 18th December 2011]; Available from: http://www.who.int/
immunization_monitoring/diseases/meningitis_surveillance.
28. Fishman RA: Cerebrospinal fluid in diseases of the nervous system.
Philadelphia: saunders; 1992.
29. Popovic T, Ajello G, Facklam R: WHO laboratory Manual for the diagnosis of
Meningitis Caused by Neisseria meningitidis, Streptococcus pneumoniae, and
Haemophilus influenzae. Geneva: World Health Organisation; 1999.
30. Alandu A-H: Outbreaks of cerebrospinal meningitis in upper east region.
In Daily Graphic. Accra: Ghana Broadcasting Corporation; 2012:3.
31. Woods CW, et al: Emergency vaccination against epidemic meningitis in
Ghana: implications for the control of meningococcal disease in West
Africa. Lancet 2000, 355(9197):30–33.
32. Frimpong EH, Lartey RA: Study of the aetiologic agents of meningitis in
Kumasi, Ghana, with special reference to Cryptococcal neoformans. East
Afr Med J 1998, 75(9):516–519.
33. Afifi S, et al: Laboratory-based surveillance of patients with bacterial
meningitis in Egypt (1998-2004). Eur J Clin Microbiol Infect Dis 2007, 26
(5):331–340.
34. Ba O, et al: Hospital surveillance of childhood bacterial meningitis in
Senegal and the introduction of Haemophilus influenzae type b
conjugate vaccine. AmJTrop Med Hyg 2010, 83(6):1330–1335.
35. Sacchi CT, et al: Incorporation of real-time PCR into routine public health
surveillance of culture negative bacterial meningitis in Sao Paulo. Brazil.
PLoS One 2011, 6(6):e20675.
36. Jbara I, et al: Comparison of culture and polymerase chain reaction
methods for the detection of Haemophilus influenzae, Streptococcus
pneumoniae and Moraxella catarrhalis in cerebrospinal fluids and
middle ear effusions. Mikrobiyol Bul 2007, 41(4):495–502.
37. Kilpatrick ME, Mikhail IA, Girgis NI: Negative cultures of cerebrospinal fluid
in partially treated bacterial meningitis. Trop Geogr Med 1987,
39(4):345–349.
38. Gordon SB, et al: Bacterial meningitis in Malawian adults: pneumococcal
disease is common, severe, and seasonal. Clin Infect Dis 2000, 31(1):53–57.
39. Denno DM, et al: Nasopharyngeal carriage and susceptibility patterns of
Streptococcus pneumoniae in Kumasi, Ghana. West Afr J Med 2002,
21(3):233–236.
40. Cutts FT, et al: Efficacy of nine-valent pneumococcal conjugate vaccine
against pneumonia and invasive pneumococcal disease in The Gambia:
randomised, double-blind, placebo-controlled trial. Lancet 2005,
365(9465):1139–1146.
41. Arda B, et al: Pooled analysis of 2,408 cases of acute adult purulent
meningitis from Turkey. Med Princ Pract 2008, 17(1):76–79.
42. Thigpen MC, et al: Bacterial Meningitis in the United States, 1998–2007. N
Engl J Med 2011, 364(21):2016–2025.
43. Milledge J, et al: Aetiology of neonatal sepsis in Blantyre, Malawi: 1996-
2001. Ann Trop Paediatr 2005, 25(2):101–110.
44. Gebremariam A: Neonatal meningitis in Addis Ababa: a 10-year review.
Ann Trop Paediatr 1998, 18(4):279–283.
45. Longe AC, Omene JA, Okolo AA: Neonatal meningitis in Nigerian infants.
Acta Paediatr Scand 1984, 73(4):477–481.
Owusu et al. Annals of Clinical Microbiology and Antimicrobials 2012, 11:28 Page 8 of 8
http://www.ann-clinmicrob.com/content/11/1/2846. Berardi A, et al: Neonatal bacterial meningitis. Minerva Pediatr 2010,
62(3 Suppl 1):51–54.
47. Minta DK, et al: Neuromeningeal cryptococcosis in Mali]. Med Trop (Mars)
2011, 71(6):591–595.
48. Maher D, Mwandumba H: Cryptococcal meningitis in Lilongwe and
Blantyre, Malawi. J Infect 1994, 28(1):59–64.
49. Muyembe Tamfum JJ, et al: Cryptococcosis caused by Cryptococcus
neoformans var. Gattii. A case associated with acquired
immunodeficiency syndrome (AIDS) in Kinshasa, Zaire. Med Trop (Mars)
1992, 52(4):435–438.
50. Adjei O, Agbemadzo T: Susceptibility of Streptococcus pneumoniae
strains isolated from cerebrospinal fluid in Ghana. J Antimicrob Chemother
1996, 38(4):746–747.
51. Drugs and Therapeutics Committee: A guide to antimicrobial use. Kumasi:
Komfo Anokye Teaching Hospital (KATH); 2002.
52. Greenwood B: Manson Lecture. Meningococcal meningitis in Africa. Trans
R Soc Trop Med Hyg 1999, 93(4):341–353.
doi:10.1186/1476-0711-11-28
Cite this article as: Owusu et al.: Aetiological agents of cerebrospinal
meningitis: a retrospective study from a teaching hospital in Ghana.
Annals of Clinical Microbiology and Antimicrobials 2012 11:28.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
